Learn more →
Back to Expert Scholars
clinical / clinicalPatient Advocacy & Quality of Care

Shelley Hwang

谢利·黄

MD, MPH

🏢Duke University Medical Center(杜克大学医学中心)🌐USA

Mary and Deryl Hart Distinguished Professor of Surgery; Chief, Breast SurgeryMary and Deryl Hart外科杰出教授;乳腺外科主任

52
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Shelley Hwang is a pioneering breast surgical oncologist and quality advocate who leads the landmark COMET trial testing active surveillance versus standard surgery for low-risk DCIS. She champions value-based care and de-escalation of treatment for low-risk breast cancer, seeking to reduce overtreatment while preserving patient quality of life.

Share:

🧪Research Fields 研究领域

Breast Cancer Active Surveillance乳腺癌主动监测
DCIS Management & COMET Trial导管原位癌管理与COMET试验
Value-Based Breast Cancer Care价值导向乳腺癌护理
Low-Risk Breast Cancer De-escalation低危乳腺癌降级治疗
Shared Decision Making in Breast Cancer乳腺癌共同决策

🎓Key Contributions 主要贡献

COMET Active Surveillance Trial

Led the COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial, the first randomized US trial evaluating active surveillance versus surgery for low-risk DCIS, with quality of life as a co-primary endpoint.

De-escalation of Breast Cancer Treatment

Advanced evidence and advocacy for treating low-risk breast cancer with less-aggressive approaches, improving quality of life while maintaining safety—a paradigm shift in breast cancer care delivery.

Patient-Centered Outcomes in Breast Surgery

Embedded shared decision-making tools and PRO collection into breast surgery practice at Duke, and led research on how treatment choices align with patient values for low-risk breast cancer.

Representative Works 代表性著作

[1]

Active Surveillance for DCIS: The COMET Trial

NEJM Evidence (2024)

Results of the landmark COMET randomized trial showing non-inferiority of active surveillance versus surgery for quality of life in low-risk DCIS patients.

[2]

Risk-Stratified Management of DCIS: What Does the Future Hold?

Journal of Clinical Oncology (2019)

Framework for risk-stratified approaches to DCIS management, integrating molecular markers and patient preferences to individualize treatment.

[3]

Patient Values, Preferences, and Low-Risk DCIS Decision Making

Annals of Surgical Oncology (2021)

Survey study revealing how patient values and risk tolerance drive treatment choices in low-risk DCIS, supporting tailored shared decision-making.

🏆Awards & Recognition 奖项与荣誉

🏆Susan G. Komen Leadership Award
🏆ASCO Young Investigator Award
🏆Society of Surgical Oncology James Ewing Lectureship
🏆Doris Duke Charitable Foundation Clinical Scientist Development Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 谢利·黄 的研究动态

Follow Shelley Hwang's research updates

留下邮箱,当我们发布与 Shelley Hwang(Duke University Medical Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment